A carregar...
Perspectives: Other ErbB2-Targeted Therapies
SUMMARY: Despite the success of individualized targeted therapies in women with breast cancer with current available compounds, new drugs – especially with different mechanisms of resistance – are under development. A range of novel targeted agents for women with tumors that overexpress ErbB2 (HER2)...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931098/ https://ncbi.nlm.nih.gov/pubmed/20847930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285779 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|